Iain Stuart
2022
In 2022, Iain Stuart earned a total compensation of $653.9K as Chief Scientific Officer at VYNE Therapeutics, a 49% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,415 |
|---|---|
| Option Awards | $30,750 |
| Salary | $421,811 |
| Stock Awards | $45,750 |
| Other | $12,200 |
| Total | $653,926 |
Stuart received $421.8K in salary, accounting for 65% of the total pay in 2022.
Stuart also received $143.4K in non-equity incentive plan, $30.8K in option awards, $45.8K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Iain Stuart's compensation ranked 3,898th out of 5,736 executives tracked by ExecPay. In other words, Stuart earned more than 32.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,898 out of 5,736 | 32nd |
Division Manufacturing | 2,207 out of 3,125 | 29th |
Major group Chemicals And Allied Products | 1,069 out of 1,416 | 25th |
Industry group Drugs | 1,003 out of 1,317 | 24th |
Industry Pharmaceutical Preparations | 735 out of 963 | 24th |
Source: SEC filing on November 13, 2023.
Stuart's colleagues
We found two more compensation records of executives who worked with Iain Stuart at VYNE Therapeutics in 2022.